PHARMCO II ApS: Financial statements 2022
CVR: 25202899
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -1,724,091 compared with DKK 4,171,520 the year before. Equity in the 2022 report amounted to DKK 72,096,378. The solvency ratio was 75.6%. The company had 63 employees in the financial year.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,724,091
- Equity
- DKK 72,096,378
- Total Assets
- DKK 95,368,650
- Employees
- 63
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 0 | -1.7 mio. | 72.1 mio. | 63 |
| 2021 | - | 0 | 4.2 mio. | 73.8 mio. | 49 |
| 2020 | - | -20 t. | 2.8 mio. | 69.7 mio. | 48 |
| 2019 | - | -19 t. | 1.5 mio. | 66.9 mio. | - |
| 2018 | - | -19 t. | 1.7 mio. | 61.2 mio. | - |
Official annual report
Keep an eye on PHARMCO II ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMCO II ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK 4,171,520.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.